8 months ago
CRVO
AnalystsSoumit RoySoumit Roy's Stock Forecasts
AnalystsSoumit Roy
Sectors:
Analyst Ranking
Top 43%
#2180 out of 5077 analysts
Average Return
+0.35%
Win Rate
29%10 out of 34
Risk vs Reward
Poor
Good
Soumit Roy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +727.79% | $3.85 | $31.87 | 2024-04-10 - 2025-04-10 | Strong Buy |
Elicio Therapeutics IncELTX | +127.70% | $4.26 | $9.70 | 2024-10-30 - 2025-10-24 | Strong Buy |
Nuvation Bio IncNUVB | +116.52% | $2.24 | $4.85 | 2025-03-11 - 2025-10-24 | Strong Buy |
Cullinan Therapeutics IncCGEM | +86.53% | $8.76 | $16.34 | 2023-10-05 - 2024-10-04 | Strong Buy |
Protara Therapeutics IncTARA | +60.88% | $3.17 | $5.10 | 2025-05-21 - 2025-10-24 | Strong Buy |
Soumit Roy Analyst Color
Get additional color on Soumit Roy's coverage of popular stocks
Soumit Roy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cg Oncology IncCGON | 1 | Strong Buy | $50.00 | +14.50% | Initiates Coverage On | 2 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $21.00 | +311.76% | Initiates Coverage On | 5 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $40.00 | +115.05% | Initiates Coverage On | 5 months ago |
Enliven Therapeutics IncELVN | 2 | Strong Buy | $27.00 | +31.00% | Maintains | 5 months ago |
Cervomed IncCRVO | 2 | Strong Buy | $15.00 | +112.16% | Upgrades | 8 months ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $10.00 | +106.19% | Initiates Coverage On | 8 months ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $34.00 | +21.60% | Upgrades | 8 months ago |
Chimerix IncCMRX | 1 | Hold | $8.55 | +0.12% | Downgrades | 8 months ago |
In8bio IncINAB | 3 | Strong Buy | $36.00 | +1,582.24% | Upgrades | 9 months ago |
Onkure Therapeutics IncOKUR | 1 | Strong Buy | $32.00 | +863.86% | Initiates Coverage On | 9 months ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $16.00 | +665.55% | Initiates Coverage On | 9 months ago |
Elicio Therapeutics IncELTX | 1 | Strong Buy | $9.00 | -7.22% | Initiates Coverage On | a year ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $17.00 | +29.77% | Initiates Coverage On | a year ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Adicet Bio IncACET | 2 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Hold | $25.60 | N/A | Downgrades | a year ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $26.00 | N/A | Maintains | 2 years ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 2 years ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $10.00 | N/A | Upgrades | 2 years ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Oncolytics Biotech IncONCY | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Coeptis Therapeutics Holdings IncCOEP | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibikase Therapeutics IncIKT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Ars Pharmaceuticals IncSPRY | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Tracon Pharmaceuticals IncTCON | 1 | Strong Buy | $340.00 | N/A | Initiates Coverage On | 5 years ago |
Celyad Oncology SaCYADY | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 5 years ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $810.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.